CD146+CECs were 43±23/mL in healthy subject (n = 50), 103±83/mL in breast cancer patients (n = 64, p<0.0001) and 117±87 in glioblastoma patients (n = 134, p<0.0001). This evidence concerns the gene MCAM and breast cancer.